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DETERMINING CELLULAR AND BIOCHEMICAL FUNCTION OF A NOVEL 
ADHESION MOLECULE IN THE KIDNEY. 
EMAD ARAFA. 
ABSTRACT 
Acute kidney injury is an abrupt loss of kidney function that 
develops in short time with limited effective treatments other than kidney 
transplantation. We have identified TMIGD1 (Transmembrane immuno- 
globulin domain 1) as a novel receptor expressed in various organs and 
tissues, mainly in cell with epithelial origin. TMIGD1 regulates cell 
morphology and adhesion and its extracellular domain mediates its 
activity. Knocking down of TMIGD1 using short hairpin RNA (shRNA) 
increased cell death in human kidney epithelial cells (HK2). On the other 
hand, HEK293 cells over expressing TMIGD1 protected cells from oxidative 
stress and nutrient deprivation induced injuries. Furthermore, TMIGD1 
expression is reduced in vivo and in vitro kidney injury models. TMIGD1 
expression was regulated by ubiquitination and degradation by 
proteosome 26s. Thus, we present TMIGD1 as a novel receptor that plays 
important roles in regulation of cell morphology, cell- cell interaction and 
cell survival. 
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INTRODUCTION 
 
 1.1. The human genome is composed of about 20,000 protein coding 
genes and approximately the same number of genes for non-coding RNAs 
(rRNA, tRNA) 1. Every tissue and cell has a complete set of genes, however at 
any given time cells use only a fraction of the genes in their genome1. The 
characteristic pattern of transcribed genes is what defines the phenotype of the 
tissue or cell1. This characteristic pattern changes once exposed to a signal such 
as a dietary or a stress molecule1.  Moreover, tissue and signal specific gene 
expression provides a central mechanism to control the general properties of a 
cell and its response to environmental perturbations1. A detailed understanding 
of gene expression and regulation can therefore bear the potential for 
understanding dysregulation in diseased state and can provide possible 
therapeutic treatments1.  
The importance of gene expression and regulation becomes apparent 
when cells become specialized for certain tasks and it allow cells to adjust and 
adapt to the ever changing conditions1. Regulated genes opposite to constitutive 
genes that are always active represent the blueprints for proteins that are needed 
by the cells to function under diverse conditions1.  Gene Expression can be 
regulated on different levels; most commonly on the transcriptional level where 
either tightly condensed chromatin prevents or limits DNA binding transcription 
factors from gaining access to promoter, enhancer or silencer regions in DNA, or 
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preventing RNA polymerase from binding and transcribing DNA2. In addition, 
gene expression can be regulated on the translational level by controlling the 
ability of pre-mRNA to be converted into a mature mRNA molecule and by 
controlling the stability of mRNA and how long it remains viable to be translated2. 
Finally, gene expression can be regulated on the protein level, where a protein 
can be subjected to post translational modifications, which can activate, 
deactivate, modify function, modify location or degrade the protein2. 
1.2. Oxidative stress and cell injury: a condition caused by the accumulation of 
reactive oxygen species and the inability of the different biological systems to 
readily detoxify the reactive intermediates or to restore the ensuing damage3. 
This imbalance in the normal redox state of cells can cause toxic effects through 
the production of peroxides and free radicals that damage all components of the 
cell, including proteins, lipids and DNA3. Furthermore, some reactive oxidative 
species act as cellular messengers in redox signaling. Thus, oxidative stress can 
cause disruptions in normal mechanisms of cellular signaling3. 
Oxidative stress is associated with increased production of oxidizing 
species or a significant decline in the effectiveness of antioxidant defenses, such 
as Glutathione4. The severity of oxidative stress depends upon the size of these 
changes, with a cell being able to tolerate small perturbations and to recover to 
its original state5. However, more severe oxidative stress can lead to cell death 
and even moderate oxidation can trigger apoptosis, while more intense stresses 
may cause necrosis5.   
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In humans, oxidative stress is thought to be associated in the 
development of cancer6, several kidney diseases7, cardiovascular diseases8,9, 
and several systemic diseases such as hypertension10, diabetes and mellitus7. In 
cancer, oxidative stress is likely to be involved in age-related development of 
cancer6. The reactive species produced in oxidative stress can cause direct 
damage to the DNA and are therefore mutagenic, and it may also suppress 
apoptosis and promote proliferation, invasiveness and metastasis3.  
In addition, in cardiovascular diseases, oxidation of LDL in the vascular 
endothelium is a precursor to plaque formation11where it plays a significant role 
in the ischemia injury due to oxygen reperfusion following hypoxia11.  
On the contrary, reactive oxygen species can be beneficial when the 
immune system uses the lethal effects of oxidants by exploiting the generated 
oxidizing species to kill pathogens through a mechanism involving 
activated phagocytes producing both ROS and reactive nitrogen species12. 
Although the use of these highly reactive compounds in the cytotoxic response of 
phagocytes causes damage to host tissues, the non-specificity of these oxidants 
is an advantage since they will damage almost every part of their target 
cell12. This prevents a pathogen from escaping this part of immune response by 
mutation of a single molecular target12. Furthermore, reactive oxygen species 
play important roles in cell signaling, a process termed redox signaling 13. Thus, 
to maintain proper cellular homeostasis, a balance must be struck between 
reactive oxygen production and consumption13. 
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1.3. The Kidneys; Two bean shaped kidneys are retroperitoneal organs on 
either side the vertebral column consisting of 1 million nephrons, which 
represents the fundamental functional units of kidney.14. The kidneys have a 
tough fibrous capsule (irregular dense connective tissue) for protection. 
Otherwise, they have very little connective tissue between the nephrons14. The 
kidney contains about 1 million functional units called nephrons, which are 
continuous with a system of collecting tubules15-17. The nephrons with several 
segments and compartments are responsible for distinct functions including 
filtration, excretion, resorption, and regulation of ion balance, and water content. 
Hence, their function extends to stabilize blood pressure15-17. This regulation of 
ion balance and water content (osmoregulation) of the blood plasma means that 
all the other body fluids will also be regulated15. 
On a histological section, the kidney can be identified by the presence of 
the renal corpuscale and kidney tubules14. The tubules are lined by cuboidal 
epithelium14. The renal corpuscule is surrounded by Bowman’s capsule which is 
made of squamous epithelium14. The kidney can also be identified by a tuft of 
capillaries appearing as a large cellular mass known as glomerulus.   The 
kidneys can be subjected to both acute and chronic injuries, which if not 
managed properly can lead to chronic kidney disease (CKD) failure, a condition 
compromising several renal functions and is associated with high morbidity and 
mortality15-17.  
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1.4. Cell Adhesion Molecules: Cell adhesion molecules are cell surface 
proteins involved in cell- cell interaction, cell- extracellular matrix binding and 
organization of tissue structure. Adhesion molecules are commonly trans-
membrane receptors composed of an intracellular domain that stabilizes the 
protein in the cytoskeleton, a trans-membrane domain, and an extracellular 
domain that is responsible for these proteins interactions with other cell adhesion 
molecules or the surrounding extracellular matrix18. Adhesion molecules can be 
divided into distinct families with adhesive interactions varying in strength from 
strong binding involved in the maintenance of tissue architecture to a more 
transient, less avid, dynamic interactions observed in leukocyte biology19. 
Adhesion molecules have a wide range of physical and biochemical functions 
providing signals that can regulate cell proliferation, gene expression, 
differentiation, apoptosis and migration19. Reduced expression and abnormalities 
of adhesion molecules have been implicated in many disease including cancer21, 
cardiovascular diseases22 and renal diseases20,23. 
1.5. Immunoglobulin and proline rich receptor (IGPR-1): Recently, IGPR-1 
was identified as a novel cell adhesion molecule encoded by TMIGD2 (trans-
membrane and Immunoglobulin domain containing 2)24. IGPR-1/TMIGD2 was 
found to be expressed in human endothelial and epithelial cells but was found to 
be absent in mouse genome24. IGPR-1 has been implicated in angiogenesis, 
regulation of endothelial capillary tube formation and cell migration24. Further 
investigation resulted in the identification of a second family member of IGPR-1. 
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TMIGD1 (trans-membrane and immunoglobulin domain containing 1) unlike 
IGPR-1 is conserved among most species including human and mouse.  The 
overall goal of this thesis project was to determine expression and biological 
function of TMIGD1 in human kidney epithelial cells. The work presented in this 
thesis work for the first time demonstrates that TMIGD1 is expressed in kidney 
tubular epithelial cells and acts to protect kidney epithelial cells from oxidative 
cell injury as exhibited by the data shown in this manuscript. 
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METHODS AND MATERIALS 
 
2.1. Plasmids, siRNA and antibodies:  
Mouse TMIGD1 clone (cDNA clone MGC: 74197, IMAGE: 30311543) was 
purchased from Open Biosystems and subsequently was cloned as a c-
myc tag in its C-terminus into retroviral pQCXIP vector via NotI and 
BamH1 sites (vetrogen Inc.). C-myc tagged TMIGD1 was further 
sequenced to confirm its sequence identity. Rabbit polyclonal anti-
TMIGD1 antibody was made against a peptide corresponding to 20 amino 
acids in the extracellular domain of TMIGD1. 
2.2.  Cell lines and culture: 
All cell lines HK2 (human kidney tubular epithelial cells), HEK293 (human 
embryonic kidney epithelial cells)) were grown in DMEM supplemented 
with 10% FBS and the antibiotic Streptomycin. HEK 293 cell lines were 
engineered to express either an empty vector (PMSCV), TMIGD1 with a 
Myc tag. HK2 cell lines were engineered to express an empty vector or 
had TMIGD1 knocked down from it. pMSCV puro retroviral vector was 
used to clone Myc-tag TMIGD1. Viruses were produced in 293-GPG cells 
The viral supernatant was collected for 7 days, concentrated by 
centrifugation, added to the HEK293 cell line, 24 hours later DMEM media 
supplemented with 10% FBS, Streptomycin and 1 ug/ml Puromycin  was 
used to select the newly engineered HEK293 cells. Cells expressing the 
chimeric VEGFR-2 (herein referred to as CKR) were established by a 
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retroviral system. Briefly, the cDNA for CKR was cloned into a retroviral 
vectors (pLNCX2 ) and transfected into 293GPG cells. The viral 
supernatant was collected for 7 days, concentrated by centrifugation, and 
used as described previously (25).  
2.3.  Immunoprecipitation and western blotting:  
Cells were prepared and lysed as described 25. Briefly, cells were washed 
twice with H/S buffer (25 mM HEPES (pH 7.4), 150 mM NaCl, and 2 
mM Na3VO4) and lysed in EB lysis buffer (10 mM Tris-HCl,10% glycerol 
(pH 7.4), 5 mMEDTA, 50 mM NaCl, 50 mM NaF, 1% Triton X-100, 1 
mM PMSF, 2 mM Na3VO4, and 20 μg/ml aprotinin).. The normalized cell 
lysates were immunoprecipitated by using the appropriate antibodies and 
were subsequently subjected to Western blotting using the appropriate 
antibody as indicated in the figure legends. In some instances, the 
membranes were stripped by incubating them in a buffer containing 6.25 
mM Tris-HCl (pH 6.8), 2% SDS, and 100 mM β-mercaptoethanol in 50 °C 
for 30 min and reprobed with the desired antibody. 
2.4.  In Vitro GST Pull-down Assay:  
The extracellular domain of TMIGD1 encompassing the immunoglobulin 
domains was cloned into pGX2T vector and recombinant protein was 
prepared as described 2. The purified GST-fusion TMIGD1 protein 
subsequently was used for GST pull down assay. The assay was 
performed as described 26. Briefly, HEK-293 cells expressing TMIGD1 
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were grown in 10-cm plates. The plates were washed with H/S buffer and 
lysed in EB lysis buffer. The normalized cell lysates were incubated with 
equal amounts of immobilized GST fusionTMIGD1 or GST control for 3 h 
at 4 °C. The beads were washed with phosphate buffered saline solution 
with protease inhibitors. The eluted proteins were boiled in sample buffer 
and analyzed by Western blotting using the appropriate antibody. 
2.5.  Cell survival Assay:  
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole 
(MTT) assay was used to measure cell survival as described 27. In brief, 
cells (5X104) were seeded in 24-well plates after 24 hours of transfection 
(quadruple wells/group). Cells were washed with PBS and replaced with 
serum-free medium or other conditions as indicated in the figure legends. 
MTT assay was added in a 5ul/100ul concentration for 2 hours, then a 
stop solution was added for 1 hour and finally MTT assay was read using 
an ELISA plate reader at 570 wavelength absorbance. 
2.6.  Immunohistochemistry analysis:  
Immunohistochemistry staining was performed as per the manufacturer’s 
instruction using the EXPOSE Rabbit specific HRP/DAB detection IHC kit 
(Abcam, Cambridge, USA). 
2.7.   Cell Traction Force Microscopy: 
A Polyacrylamide gel substrate was prepared in a circular dish by mixing 
fluorescent microbeads with acrylamide/ bis-acrylamide in a pre-
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determined bis-acrylamide to acrylamide ratio28. The gel disk is further 
coated with collagen type I before cells are plated on it. Cells were 
afterwards plated in two concentrations 1:10000 and 1:20000. 
Later on several separate cells in each dish were chosen for imaging at 
different time intervals on an inverted microscope (Nicon deconvolution 
wide field epifluorescence microscope). This yields “force loaded” images. 
The cells in the dish are detached afterwards by trypsinization, and an 
image of the same location is taken. This is denoted as the “null force” 
image.  the force loaded and null force images are then aligned using  
Adobe photo-shop and the fluorescent micro-beads serve as markers for 
tracking the movement of the substrate under CTFs. By locating the 
micro-beads in the images taken before and after straining poly-
acrylamide gel substrate, micro-bead movements are determined. 
2.8.   Animal models: DOCA salt uninephrectomy model:  
Ten to twelve week old 129/SVE mice were obtained from Taconic Farms. 
After a week of acclimatizing, surgeries were performed on mice. Mice 
were anesthetized by isoflurane inhalation after which right 
uninephrectomy was performed followed by implantation of a 21-day 
release DOCA salt pellet (Innovative research of America). After recovery 
from anesthesia, animals were housed singly in cages and fed on 
standard chow and given 1% saline as source of drinking water. Control 
animals were maintained on standard chow and tap water. For 
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immunohistochemistry studies, mice were killed at 0, 24 hours and 2 
weeks after DOCA-salt uninephrectomy treatment. 
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RESULTS 
 
 
 3.1. Development and characterization of polyclonal anti-TMIGD1 
antibody:  
To study the TMIGD1 gene, we developed a polyclonal rabbit anti-
TMIGD1 antibody. We tested the ability of anti-TMIGD1 antibody to detect 
TMIGD1 using cell lysates derived from HEK-293 cells over-expressing c-Myc 
tagged TMIGD1. The initial western blot analysis showed that the anti-c-Myc 
antibody detects TMIGD1 with an approximate molecular weight of 45kDa 
(Figure 1A). The same protein band in cells expressing TMIGD1 and a weaker 
band in the cells expressing control vector were also detected when 
immunoblotted with anti-TMIGD1 antibody (Figure 1A). The weaker band 
detected in the HEK-293 cells expressing empty vector most likely corresponds 
to endogenously expressed TMIGD1 (Figure 1A). To determine whether TMIGD1 
antibody was specific, the anti-TMIGD1 antibody was pre-incubated with the 
peptide that was used to generate anti-TMIGD1 antibody. The pre-incubation of 
the anti-TMIGD1 antibody with peptide blocked the detection of both endogenous 
and over-expressed TMIGD1 (Figure 1B), indicating that the anti-TMIGD1 
antibody specifically recognizes TMIGD1. The predicted molecular weight of 
TMIGD1 is 29kDa, however both anti-c-myc and anti-TMIGD1 antibodies 
detected TMIGD1 with approximate molecular weight of 45kDa. The higher 
molecular weight of TMIGD1 suggests that TMIGD1 likely undergoes post-
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translational modifications (PTM) such as glycosylation, which is a common PTM 
for cell surface proteins. The data demonstrate that the anti-TMIGD1 antibody 
specifically recognizes TMIGD1. 
3.2. TMIGD1 regulates cellular morphology: 
Interesting, we noticed that over-expression of TMIGD1 in HEK-293 cells 
alters cell morphology. HEK-293 cells expressing TMIGD1 appear to be more 
spreading, more flattened, larger and with less podia compared to HEK-293 cells 
expressing empty vector (Figure 2A). The data suggests that TMIGD1 is involved 
in the regulation of cell morphology. Immunohistochemistry analysis using anti-
TMIGD1 antibody showed that TMIGD1 tends to be expressed in epithelial cells, 
most specifically in epithelial cells of the kidney (Figure 2B). Furthermore, 
examination of the expression of TMIGD1 in different epithelial tumor cells line, 
revealed that TMIGD1 is expressed in colorectal and clear cell renal cell 
carcinoma cell lines (Figure 2C). 
3.3. The extracellular domain mediates dimerization of TMIGD1: 
Immunoglobulin domains are known to be involved in protein-protein 
interaction29, consistent with its known function, a GST-fusion recombinant 
protein of extracellular domain of TMIGD1 encompassing its two immunoglobulin 
domains showed that it binds to TMIGD1 (Figure 3A). The data suggests that 
immunoglobulin domains of TMIGD1 act as self-dimerizing domains to mediate 
its function.  
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Given that cell adhesion molecules are known to regulate cell motility, we 
investigated the role of TMIGD1 in cellular traction. HEK-293 cells over-
expressing TMIGD1 showed significantly lower cell traction values of 
(94.71±27.89 Pa) compared to HEK- 293 cells expressing the empty vector of 
(64.87±38.23 Pa). Confluent cell layers expressing TMIGD1 plated on poly-
acrylamide gel substrate exhibited increased cell spreading similar to that 
observed on collagen coated plastic plates. Thus, indicating that there is less 
motility and migration of HEK293 over-expressing TMIGD1. No obvious 
differences were observed in cellular spreading in single cells present on the 
collagen coated polyacrylamide gel substrate (Figure 3B). On the whole, these 
findings suggests that the functional effects observed in the presence of TMIGD1 
requires cell to cell interaction a typical feature of proximal tubular/kidney 
function. Thus, TMIGD1 undergoes trans-dimerization and regulates cellular 
traction (Figure 3C).  
3.4. TMIGD1 expression is down- regulated in kidney hypertensive model: 
We studied TMIGD1 expression in a hypertensive mouse model of kidney 
disease. A uninephrectomy was done on 8-10 weeks old mice after which 
DOCA-salt pellet was planted subcutaneously and the mice given 1% saline. 
Kidney tissues were harvested 24 hours and 2 weeks after treatment to study 
differences in earlier protein expression changes as compared to late changes. 
After 24 hours and 2 weeks of inducing hypertension, there was a marked 
decline in TMIGD1 staining in morphologically normal proximal and/or distal 
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tubules compared to tubules in non-hypertensive mice (Figure 4). I thought you 
had data about its localization in the tubular cell--- is it apical or basolateral The 
data suggests that TMIGD1 expression is affected in the mouse experimental 
model of hypertension.   
 
3.5. TMIGD1 reduces cell death in response to H2O2 induced cell injury and 
nutrient deprivation in human kidney cells: 
Considering that expression of TMIGD1 was down regulated in the mouse 
experimental model of hypertension, we decided to examine possible function of 
TMIGD1 in the kidney epithelial cells. For this purpose, we knocked down 
TMIGD1 in HK2 cells (Figure 5C) and examined the effect of nutrient deprivation 
(hypoglycemia) and H2O2-induced cell injuries. Oxidative stress is a uniform 
underlying pathogenic mechanism of renal progression irrespective of inciting 
factor. Several previous studies and animal models show H2O2 induce nascent 
oxygen and compromises survival of renal tubular epithelial cells. Since TMIGD1 
expression is down regulated in hypertensive CKD model and that TMIGD1 
enhances tubular survival, we hypothesized that TMIGD1 abrogates H2O2’s 
effect on renal epithelial cell7. The results showed that engineered HK2 with 
TMIGD1 knocked down had a considerable less survival (12% survival versus 
28% survival with control SiRNA) when treated with hydrogen peroxide (Figure  
5A). Furthermore, engineered HK2 with TMIGD1 knocked down had a reduced 
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survival when grown in a nutrient deficient media (serum free, 5mM glucose) 
(Figure 5B). Our data suggests the importance of TMIGD1 for the survival of 
kidney epithelial cells in response to cell injuries induced by hydrogen peroxide 
and nutrient deprivation. To support our  
Since, knockdown of TMIGD1 increased susceptibility of HK2 cells to H2O2-
induced cell injury, we over expressed  TMIGD1 in HEK293 and examined the 
effect of over-expression of TMIGD1( Figure 6D). Over-expression of TMIGD1 in 
HEK293 cells improved cell survival in response to hydrogen peroxide induced 
injury as depicted in (Figure 6A). Addition of N-acetyl cysteine antioxidant (free 
radical scavenger) markedly reversed the effect of hydrogen peroxide (Figure 
6B). In addition, TMIGD1 over expressed in HEK-293 cells increased cell survival 
in response to nutrient deprivation (hypoglycemia) as well (Figure 6C). The data 
suggest that TMIGD1 significantly contributes to survival of kidney epithelial cells 
in response to cell injury.   
3.6. Hydrogen peroxide induces down regulation and ubiquitination of 
TMIGD1:  
To study the molecular mechanism of downregulation of TMIGD1 in 
kidney cells, we tested whether hydrogen peroxide treatment induces down 
regulation and ubiquitination of TMIGD1 as a mean to stimulate cell death. Our 
results show that TMIGD1 is down regulated in response to hydrogen peroxide 
treatment in both HK2 and HEK293 cell lines (Figure 7A). Treatment of cells with 
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proteosome inhibitors, like Bortezomib and MG132, restore the hydrogen 
peroxide–mediated down-regulation of TMIGD1 (Figure 7B). Furthermore, 
ubiquitination of TMIGD1 in HK2 cells was robustly increased in response to 
hydrogen peroxide treatment (Figure 7C). To support our work, we examined the 
effect of Bortezomib treatment on the survival of HK2 cells. Our results show that 
when HK2 cells are treated with both hydrogen peroxide and Bortezomib, the 
Bortezomib treatment helps HK2 cells recover from the cell death induced by 
hydrogen peroxide (Figure 7D).  
Overall, our work demonstrates that TMIGD1 protects kidney epithelial 
cells from cell induced injury by hydrogen peroxide and nutrient deprivation. 
Thus, our work shows that hydrogen peroxide down regulates TMIGD1 
expression and increases ubiquitination and degradation of TMIGD1 (Figure 8A).  
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Development and characterization of polyclonal anti-TMIGD1 antibody: A) 
Whole cell lysates from HEK-293 cells expressing empty vector (pMSCV) or c-
Myc-tag-TMIGD1 were blotted with anti-c-Myc antibody and anti-TMIGD-1 
antibody. B) To demonstrate the specificity of the anti-TMIGD1 antibody was 
also pre-incubated with the TMIGD1 peptide, which was used to develop anti-
TMIGD1 antibody.  
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TMIGD1 regulation of cellular morphology: A) Shown is the typical 
morphology of HEK-293 cells expressing TMIGD1 and control cells. Pictures 
were taken under light microscope (40X). B) Immunohistochemistry of Kidney 
epithelial cells showing expression level of TMIGD1 at 20X and 100X under 
light microscope (Images courtesy of Philip Bondzie). C) TMIGD1 expression 
in human kidney cells and different tumor cell lines. 
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GST fusion of TMIGD1 binds TMIGD1: A) GST-fusion recombinant protein 
of extracellular domain of TMIGD1 encompassing its two immunoglobulin 
domains showing TMIGD1dimerization. B) The role of TMIGD1 in cellular 
traction. HEK-293 cells over-expressing TMIGD1 showed significantly lower 
cell traction values of (94.71±27.89 Pa) compared to HEK- 293 cells 
expressing the empty vector of (64.87±38.23 Pa). C) Predicted model for 
TMIGD1 dimerization and activation. 
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TMIGD1 ‘s down regulation in kidney hypertensive model: Mouse kidney 
tissues from DOCA salt uninephrectomy models were subjected to 
immunohistochemistry using anti-TMIGD1 antibody and representative 
pictures are shown. Also shown are the H&E staining of control mouse kidney. 
(Images courtesy of Philip Bondzie). 
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TMIGD1 over-expression promoting cell survival: A) HEK-293 cells 
expressing TMIGD1 or control vector were plated in 24-well plates in 
quadruple in medium plus increasing concentration of hydrogen peroxide as 
indicated.  The result is the representative of three independent 
experiments.*p< 0.05 compared to control cells expressing empty vector. B) 
HEK-293 cells expressing TMIGD1 or HEK-293 cells expressing TMIGD1 
+100mM NAC were plated in 24-well plates in quadruple in medium plus 
increasing concentration of hydrogen peroxide as indicated.  The result is the 
representative of three independent experiments.*p< 0.05 compared to control 
cells expressing empty vector.  C) HEK-293 cells expressing TMIGD1 or 
control vector were plated in 24-well plates in quadruple in low glucose (5mM) 
and serum-free medium for indicated days and cell survival was measured 
with MTT assay. The result is the representative of three independent 
experiments. *p< 0.05 compared to control cells expressing empty vector at 
day 3. D) TMIGD1 over-expression in HEK293 cell. 
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TMIGD1 knockdown increases cell death: A) HK2 cells transfected with 
control siRNA or TMIGD1 siRNA. Cells were seeded in 24-well plates (4 
wells/group) in medium containing 10% FBS. After 12 hours serum containing 
medium was replaced with serum-free medium plus hydrogen peroxide 
(0.1mM). Cells were incubated for additional 8 hours and cell survival was 
measured by MTT assay. The result is representative of tree independent 
experiments. *p< 0.05 compared to control siRNA transfected cells. Shown is 
the knockdown effect of TMIGD1 siRNA on TMIGD1 expression. B) HK2 cells 
transfected with control siRNA or TMIGD1 siRNA were incubated in low 
glucose (5mM) and serum-free medium for overnight and cell survival was 
measured by MTT assay as panel A. The result is the representative of three 
independent experiments. C) TMIGD1expression knockdown using siRNA. 
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 Hydrogen peroxide induction of down regulation and ubiquitination of 
TMIGD1: A) HK2 cells and HEK293 over-expressing TMIGD1 treated with 
different concentrations of hydrogen peroxide and whole cell lysates were 
subjected to western blot analysis using anti-TMIGD1 antibody and loading 
control Hsp70. (B) HK2 cells and HEK293 over-expressing TMIGD1 were 
treated with hydrogen peroxide in the absence or presence of proteosome 
inhibitors, Bortezomib or MG132 Cells respectively, were lysed and blotted for 
TMIGD1 and loading controls, Hsp70 and PLCγ1 respectively. (C) HK2 cells 
were incubated in serum-free medium or hydrogen peroxide and cells were 
lysed and subjected to immunoprecipitation using anti-TMIGD1 antibody 
followed by western blot using anti-ubiquitin (anti-Ub) antibody. (D) HK2 cells 
seeded in 24-well plates for overnight in 10%FBS followed by incubation of 
cells in serum-free medium (vehicle), serum-free medium plus hydrogen 
peroxide or hydrogen peroxide plus or minus proteosome inhibitor, 
Bortezomib. After 8 hours survival of cells were evaluated with MTT assay. 
The result is the representative of three independent experiments. *p< 0.05 
compared to control cells treated hydrogen peroxide only. 
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Predicted model of oxidative stress induced downregulation, 
ubiquitination and degradation of TMIGD1. 
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DISCUSSION 
 
 Kidneys consist of 1 million of functional units called nephrons which are 
responsible for filtration, excretion, resorption, and regulation of ion balance and 
water content, which all together function to stabilizes blood pressure. 15,16,17 
Nephron's functions are highly dependent on epithelial cell-cell and cell-
extracellular matrix adhesion20,29, adhesion molecules such as cadherins and 
integrins are known to play key roles as mediators of the adhesion processes 
30,31. Consistent with the conventional function of cell adhesion molecules; 
previous data obtained on TMIGD1 (unpublished data) and data presented in this 
work suggests that TMIGD1 regulates kidney epithelial cell permeability, reduces 
cell migration, inhibits cell proliferation, changes actin fibril assembly and 
promotes survival of kidney epithelial cells. We propose TMIGD1 as a novel 
gene, which is expressed in epithelial cells and functions as a cell adhesion 
molecule. 
Consistent with the linkage between the loss of cell adhesion in renal 
ischemia and cell death32,33. The newly obtained data (Figures 5 and 6) in this 
research work on TMIGD1 suggests that TMIGD1 protects and promotes cell 
survival of kidney tubular epithelial cells against oxidative stress and nutrient 
deprivation. These findings show (Figure 5) that the reduced expression of 
TMIGD1 in human kidney epithelial cell (HK-2 cells) leads to a decrease in 
survival of epithelial cells in response to hydrogen peroxide (H2O2) and nutrient 
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deprivation. Moreover, the data (Figure 6) demonstrates that over-expressing 
TMIGD1 in human embryonic kidney cells (HEK293) promotes survival of 
HEK293 cells in both hydrogen peroxide and nutrient deprivation induced 
injuries. Thus, our observation (Figure 5 and 6) suggests that TMIGD1 plays a 
significant role in renal cell injury. 
Moreover, the data also shows (Figure 7) that TMIGD1 is down regulated 
in oxidative induced injury through ubiquitination and degradation. The data also 
demonstrates that using proteasomal inhibitors such as Bortezomib and MG132 
reduces TMIGD1 degradation in HEK-293 over-expressing TMIGD1 and 
therefore, promotes HEK-293 survival in oxidative stress induced cell injury. 
Here, it is important to note that recent literature on Bortezomib shows that it has 
been explored as a possible treatment in acute renal failure34. Although 
Bortezomib is a general proteosome inhibitor, it is reasonable to speculate that 
agents that could up-regulate expression of TMIGD1 could potentially lead to the 
development of a new class of drugs for treatment of renal failure. Furthermore, 
the data gathered from cell culture allows (Figure 6) us to speculate that the loss 
of TMIGD1 in part may contribute to loss of cell adhesion and death in kidney 
epithelial cells. 
Despite recent progress in renal therapy and critical care medicine, acute 
kidney injury still carries a high morbidity and mortality rate35, underscoring the 
need for a better understating of the biological process involved in renal cell 
injury and the type of bio-molecules associated in the process.  Identification of 
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TMIGD1 as a putative molecule involved in renal cell injury and further 
characterization of its role and mechanisms involved, should provide new insight 
on the molecular mechanism of renal cell injury. In this respect, this work 
describes a newly identified gene TMIGD1 which tends to reside in epithelial 
cells in general and specifically in tubular epithelial cells of the kidneys. 
 
In general, our work predicts that TMIGD1 functions as an adhesion 
molecule that is expressed in the epithelial cells where it plays a major role in 
cell- cell and cell- extracellular matrix interactions. 
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